VGX-350

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVGX-350
Drug Alias Namegene therapy (Viral Genomix)VGX-350
ClassificationBiologics
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammatory Bowel DiseasesArthritis, RheumatoidSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVgx Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVgx Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesArthritis, RheumatoidSepsis

Other Information

ATC CodeN/A
Related LinksN/A